Advanced Machine Learning and Multiomics Reveal Tumor Dynamics and Therapeutic Opportunities in Glioblastoma Multiforme
{{output}}
Gliomas, the most prevalent primary malignant brain tumors, pose a significant clinical challenge, particularly glioblastoma (GBM), the most aggressive subtype with a median survival of just 12-15 months post-diagnosis. Molecular profiling has revolutionized G... ...
